REQUEST A DEMO
Total
USD $0.00
Search more companies

Alkaloid D.O.O. Beograd (Serbia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Alkaloid D.O.O. Beograd Profile Updated: September 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Alkaloid D.O.O. Beograd is an enterprise based in Serbia. Its main office is in Belgrade. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was incorporated on February 26, 1992. It currently has a total number of 47 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 13.53% in 2024. Its’ total assets recorded a growth of 9.05%. In 2024, Alkaloid D.O.O. Beograd’s net profit margin increased by 1.23%.

Headquarters
Milentija Popovica 5A
Belgrade; Belgrade;

Contact Details: Purchase the Alkaloid D.O.O. Beograd report to view the information.

Website: http://www.alkaloid.co.rs

Basic Information
Total Employees:
Purchase the Alkaloid D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Alkaloid D.O.O. Beograd report to view the information.
Financial Auditors:
Purchase the Alkaloid D.O.O. Beograd report to view the information.
Incorporation Date:
February 26, 1992
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Hip-Azotara D.O.O. Pancevo
Company Performance
Financial values in the chart are available after Alkaloid D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
13.53%
Total operating revenue
26.63%
Operating profit (EBIT)
67.92%
EBITDA
41.59%
Net Profit (Loss) for the Period
45.81%
Total assets
9.05%
Total equity
0.82%
Operating Profit Margin (ROS)
3.98%
Net Profit Margin
1.23%
Return on Equity (ROE)
3.84%
Debt to Equity Ratio
13.65%
Quick Ratio
-0.18%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?